General MedicationsORALGeneric
ISTURISA
OSILODROSTAT PHOSPHATE
Standard Dose
EQ 10MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary
Approval overview ISTURISA is listed in Drugs@FDA under application 212801 (NDA).
Review priority: N/A Marketing status: Discontinued Active ingredient OSILODROSTAT PHOSPHATE Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor RECORDATI RARE Submission history Latest submission status date: 2025-11-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview ISTURISA is listed in Drugs@FDA under application 212801 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient OSILODROSTAT PHOSPHATE Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor RECORDATI RARE Submission history Latest submission status date: 2025-11-04 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.